Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $12.6 Million - $15.2 Million
-123,346 Reduced 99.97%
31 $3,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $170,687 - $208,142
1,497 Added 1.23%
123,377 $14.6 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $1.29 Million - $1.58 Million
11,154 Added 10.07%
121,880 $17.2 Million
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $570,467 - $631,103
4,890 Added 4.62%
110,726 $13.1 Million
Q2 2021

Aug 12, 2021

SELL
$105.79 - $124.53 $400,520 - $471,470
-3,786 Reduced 3.45%
105,836 $12.3 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $11.3 Million - $13.3 Million
103,900 Added 1815.8%
109,622 $13.1 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $170,940 - $186,275
1,628 Added 39.77%
5,722 $627,000
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $375,174 - $455,621
4,094 New
4,094 $446,000
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $746,480 - $955,402
-9,749 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $263,844 - $385,812
-4,200 Reduced 30.11%
9,749 $769,000
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $557,421 - $620,540
-7,100 Reduced 33.73%
13,949 $1.21 Million
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $1.03 Million - $1.21 Million
-14,200 Reduced 40.28%
21,049 $1.77 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $3,973 - $4,803
-60 Reduced 0.17%
35,249 $2.82 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $6,556 - $7,427
100 Added 0.28%
35,309 $2.55 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $397,233 - $438,426
-6,900 Reduced 16.39%
35,209 $2.15 Million
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $1.14 Million - $1.29 Million
20,300 Added 93.08%
42,109 $2.52 Million
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $69,784 - $74,711
-1,300 Reduced 5.63%
21,809 $1.25 Million
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $1.11 Million - $1.24 Million
23,109
23,109 $1.23 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.